611 related articles for article (PubMed ID: 33709493)
1. Protective effects of berberine in a rat model of polycystic ovary syndrome mediated via the PI3K/AKT pathway.
Yu J; Ding C; Hua Z; Jiang X; Wang C
J Obstet Gynaecol Res; 2021 May; 47(5):1789-1803. PubMed ID: 33709493
[TBL] [Abstract][Full Text] [Related]
2. Guizhi Fuling Wan reduces autophagy of granulosa cell in rats with polycystic ovary syndrome via restoring the PI3K/AKT/mTOR signaling pathway.
Liu M; Zhu H; Zhu Y; Hu X
J Ethnopharmacol; 2021 Apr; 270():113821. PubMed ID: 33460753
[TBL] [Abstract][Full Text] [Related]
3. Berberine decreases insulin resistance in a PCOS rats by improving GLUT4: Dual regulation of the PI3K/AKT and MAPK pathways.
Zhang N; Liu X; Zhuang L; Liu X; Zhao H; Shan Y; Liu Z; Li F; Wang Y; Fang J
Regul Toxicol Pharmacol; 2020 Feb; 110():104544. PubMed ID: 31778716
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effects of Heqi san on rat model of polycystic ovary syndrome through the PI3K/AKT pathway.
Zhao H; Zhou D; Chen Y; Liu D; Chu S; Zhang S
Daru; 2017 Oct; 25(1):21. PubMed ID: 29020999
[TBL] [Abstract][Full Text] [Related]
5. Liuwei Dihuang Pills alleviate the polycystic ovary syndrome with improved insulin sensitivity through PI3K/Akt signaling pathway.
Qiu Z; Dong J; Xue C; Li X; Liu K; Liu B; Cheng J; Huang F
J Ethnopharmacol; 2020 Mar; 250():111965. PubMed ID: 31185267
[TBL] [Abstract][Full Text] [Related]
6. Curcumin Alleviates Hyperandrogenism and Promotes Follicular Proliferation in Polycystic Ovary Syndrome Rats: Insights on IRS1/PI3K/GLUT4 and PTEN Modulations.
Zheng L; Chen PF; Dai WC; Zheng ZQ; Wang HL
Chin J Integr Med; 2022 Dec; 28(12):1088-1095. PubMed ID: 36327049
[TBL] [Abstract][Full Text] [Related]
7. Novel insights into the synergistic effects of selenium nanoparticles and metformin treatment of letrozole - induced polycystic ovarian syndrome: targeting PI3K/Akt signalling pathway, redox status and mitochondrial dysfunction in ovarian tissue.
Rabah HM; Mohamed DA; Mariah RA; Abd El-Khalik SR; Khattab HA; AbuoHashish NA; Abdelsattar AM; Raslan MA; Farghal EE; Eltokhy AK
Redox Rep; 2023 Dec; 28(1):2160569. PubMed ID: 36661246
[TBL] [Abstract][Full Text] [Related]
8. Bu-shen-zhu-yun decoction inhibits granulosa cell apoptosis in rat polycystic ovary syndrome through estrogen receptor α-mediated PI3K/AKT/mTOR pathway.
Jiang X; Yuan Y; Shi M; Zhang S; Sui M; Zhou H
J Ethnopharmacol; 2022 Apr; 288():114862. PubMed ID: 34861362
[TBL] [Abstract][Full Text] [Related]
9. Melatonin alleviates insulin resistance through the PI3K/AKT signaling pathway in ovary granulosa cells of polycystic ovary syndrome.
Guo R; Zheng H; Li Q; Qiu X; Zhang J; Cheng Z
Reprod Biol; 2022 Mar; 22(1):100594. PubMed ID: 34953312
[TBL] [Abstract][Full Text] [Related]
10. Effects of total flavonoids from Eucommia ulmoides Oliv. leaves on polycystic ovary syndrome with insulin resistance model rats induced by letrozole combined with a high-fat diet.
Peng MF; Tian S; Song YG; Li CX; Miao MS; Ren Z; Li M
J Ethnopharmacol; 2021 Jun; 273():113947. PubMed ID: 33617969
[TBL] [Abstract][Full Text] [Related]
11. Cangfudaotan Decoction Alleviates Insulin Resistance and Improves Follicular Development in Rats with Polycystic Ovary Syndrome via IGF-1-PI3K/Akt-Bax/Bcl-2 Pathway.
Wang C; Ding C; Hua Z; Chen C; Yu J
Mediators Inflamm; 2020; 2020():8865647. PubMed ID: 33299379
[TBL] [Abstract][Full Text] [Related]
12. The effect of adipose-derived mesenchymal stem cell transplantation on ovarian mitochondrial dysfunction in letrozole-induced polycystic ovary syndrome in rats: the role of PI3K-AKT signaling pathway.
Abdi A; Ranjbaran M; Amidi F; Akhondzadeh F; Seifi B
J Ovarian Res; 2024 Apr; 17(1):91. PubMed ID: 38678269
[TBL] [Abstract][Full Text] [Related]
13. The ameliorating effects of Guizhi Fuling Wan combined with rosiglitazone in a rat ovarian model of polycystic ovary syndrome by the PI3K/AKT/NF-κB and Nrf2/HO-1 pathways.
Ye Y; Zhou W; Ren Y; Lu J; Chen A; Jin R; Xuan F
Gynecol Endocrinol; 2023 Dec; 39(1):2254848. PubMed ID: 37706434
[TBL] [Abstract][Full Text] [Related]
14. Network pharmacology integrated with experimental validation reveals the regulatory mechanism of action of Hehuan Yin decoction in polycystic ovary syndrome with insulin resistance.
Wu YY; Li SY; Zhu HQ; Zhuang ZM; Shao M; Chen FL; Liu CS; Tang QF
J Ethnopharmacol; 2022 May; 289():115057. PubMed ID: 35121050
[TBL] [Abstract][Full Text] [Related]
15. Metformin ameliorates polycystic ovary syndrome in a rat model by decreasing excessive autophagy in ovarian granulosa cells via the PI3K/AKT/mTOR pathway.
Xu B; Dai W; Liu L; Han H; Zhang J; Du X; Pei X; Fu X
Endocr J; 2022 Jul; 69(7):863-875. PubMed ID: 35228471
[TBL] [Abstract][Full Text] [Related]
16. Berberine exerts a protective effect on rats with polycystic ovary syndrome by inhibiting the inflammatory response and cell apoptosis.
Shen HR; Xu X; Li XL
Reprod Biol Endocrinol; 2021 Jan; 19(1):3. PubMed ID: 33407557
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone activates PI3K/Akt signaling and inhibits ROS accumulation and apoptosis in granulosa cells of patients with polycystic ovary syndrome.
Gong Y; Luo S; Fan P; Zhu H; Li Y; Huang W
Reprod Biol Endocrinol; 2020 Dec; 18(1):121. PubMed ID: 33287836
[TBL] [Abstract][Full Text] [Related]
18. Downregulated lncRNA HOTAIR ameliorates polycystic ovaries syndrome via IGF-1 mediated PI3K/Akt pathway.
Chen C; Jiang X; Ding C; Sun X; Wan L; Wang C
Gynecol Endocrinol; 2023 Jun; 39(1):2227280. PubMed ID: 37356454
[TBL] [Abstract][Full Text] [Related]
19. Chinese herbal medicine alleviates the pathogenesis of polycystic ovary syndrome by improving oxidative stress and glucose metabolism via mitochondrial Sirtuin 3 signaling.
Zhang Q; Ren J; Wang F; Li M; Pan M; Zhang H; Qu F
Phytomedicine; 2023 Jan; 109():154556. PubMed ID: 36610149
[TBL] [Abstract][Full Text] [Related]
20. Metformin and sitagliptin combination therapy ameliorates polycystic ovary syndrome with insulin resistance through upregulation of lncRNA H19.
Wang Q; Shang J; Zhang Y; Zhou W
Cell Cycle; 2019 Oct; 18(19):2538-2549. PubMed ID: 31405334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
